Abstract: An effective system for verifying safety of an artificial intelligence system includes a feature quantity information accepting unit which accepts feature quantity information that includes values of plural feature quantities, that are assumed as those used in an artificial intelligence system, in each of plural first test data used for a test for verifying safety of the artificial intelligence system; and a judgment unit which judges a first combination, that is a combination that is not included in the plural first test data, in combinations of values that plural feature quantities may take, or a second combination, with it plural correct analysis results that should be derived by the artificial intelligence are associated, in the combinations of the values that the plural feature quantities may take.

Abstract: An effective system for verifying safety of an artificial intelligence system includes a feature quantity information accepting unit which accepts feature quantity information that includes values of plural feature quantities, that are assumed as those used in an artificial intelligence system, in each of plural first test data used for a test for verifying safety of the artificial intelligence system; and a judgment unit which judges a first combination, that is a combination that is not included in the plural first test data, in combinations of values that plural feature quantities may take, or a second combination, with it plural correct analysis results that should be derived by the artificial intelligence are associated, in the combinations of the values that the plural feature quantities may take.

Abstract: A material for medical use, which contains nanofibers that are formed from a resin containing a silicone-modified polyurethane resin, and which is characterized in that: the silicone-modified polyurethane resin is a reaction product of (A) a long-chain polyol that has a number average molecular weight of 500 or more, (B) a short-chain polyol that has a number average molecular weight of less than 500, (C) an active hydrogen group-containing organopolysiloxane and (D) a polyisocyanate; and the average fiber diameter thereof is less than 2,000 nm. This material for medical use exhibits excellent performance in a biological test.

Abstract: Disclosed herein is a fiber formed from a resin including a silicone-modified polyurethane resin comprising the reaction products of a polyol (A), a chain extender (B), an active-hydrogen-group-containing organopolysiloxane (C), and a polyisocyanate (D), wherein the active-hydrogen-group-containing organopolysiloxane (C) contains an active-hydrogen-group-containing organopolysiloxane (C-1) having a carbinol group at only one terminal.

Abstract: A fiber formed from a resin including a silicone-modified polyurethane resin comprising the reaction products of a polyol (A), a chain extender (B), an active-hydrogen-group-containing organopolysiloxane (C), and a polyisocyanate (D), wherein the active-hydrogen-group-containing organopolysiloxane (C) contains an active-hydrogen-group-containing organopolysiloxane (C-1) having a carbinol group at only one terminal.

Abstract: Provided is a fiber formed from a resin containing a silicone-modified polyurethane resin. With the present invention, a characteristic fiber having excellent flexibility, slipping ability, blocking resistance, heat retaining property, water vapor permeability, water repellency, and spinnability can be provided.